Why are we so bad at treating amblyopia?

Eye

Volumn 16, Issue 4, 2002, Pages 461-462

  Gregson, R ^a  

^a ROYAL COLLEGE OF OPHTHALMOLOGISTS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIETHYLCARBAMAZINE; IVERMECTIN; LEVODOPA;

AMBLYOPIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; HUMAN; ONCHOCERCIASIS; PARENTAL BEHAVIOR; PATIENT COMPLIANCE; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM; VISUAL DISORDER;

EID: 0036321992     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700102     Document Type: Article

References (4)

1. The role of drug treatment in children with strabismus and amblyopia
2. Visual acuities after levodopa administration in amblylopia
3. Cytidine-5′-diphosphocholine improves visual acuity, contrast sensitivity and visually-evoked potentials of amblyopic subjects
4. Atropine penalisation versus occlusion as the primary treatment for amblyopia